Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Income from Continuing Operations (2016 - 2025)

Neuroone Medical Technologies' Income from Continuing Operations history spans 14 years, with the latest figure at 1437890.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 180.54% year-over-year to 1437890.0; the TTM value through Dec 2025 reached 6828586.0, up 5.0%, while the annual FY2025 figure was 3605374.0, 70.73% up from the prior year.
  • Income from Continuing Operations reached 1437890.0 in Q4 2025 per NMTC's latest filing, up from 1619221.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1785322.0 in Q4 2024 to a low of 3522828.0 in Q1 2023.
  • Average Income from Continuing Operations over 5 years is 2360506.3, with a median of 2763626.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: soared 153.37% in 2024, then plummeted 180.54% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 2807475.0 in 2021, then skyrocketed by 38.28% to 1732769.0 in 2022, then tumbled by 93.04% to 3344900.0 in 2023, then skyrocketed by 153.37% to 1785322.0 in 2024, then tumbled by 180.54% to 1437890.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Income from Continuing Operations are 1437890.0 (Q4 2025), 1619221.0 (Q3 2025), and 1500868.0 (Q2 2025).